Policy / Pricing NHS risks missing out on independent prescriber benefits PharmaphorumGaps in support could undermine a wave of new independent prescribers entering the NHS and a push for more community-based care, warns a new report.Policy / PricingRead full story pharminent April 9, 2026 (Last updated: April 9, 2026) Pharmaphorum Gaps in support could undermine a wave of new independent prescribers entering the NHS and a push for more community-based care, warns a new report. Policy / PricingRead full story Post navigation Previous: Novartis-backed Sidewinder collects $137M series B to strike at difficult-to-treat tumorsNext: Roche sticks with C4T, adding up to $1B for molecular glue partnership Related Stories Policy / Pricing UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged pharminent May 13, 2026 Policy / Pricing EU agrees plan to tackle essential medicine shortages pharminent May 12, 2026 Policy / Pricing 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar) pharminent May 12, 2026
